Loading...
Loading...
Browse all stories on DeepNewz
VisitWHO Approves Abbott's Alinity m MPXV Assay as First Mpox Test for Emergency Use
Oct 4, 2024, 07:46 AM
The World Health Organization has approved the first diagnostic test for mpox, formerly known as monkeypox, under its Emergency Use Listing procedure, marking an important milestone in expanding global access to mpox testing amid rising outbreaks in Africa. The approved test, called the Alinity m MPXV assay, is manufactured by Abbott Molecular, a division of Abbott Laboratories. This emergency use authorization enables countries to detect the virus more quickly and effectively, strengthening their responses to outbreaks.
View original story
Markets
Yes • 50%
No • 50%
Official announcements from health departments or ministries of at least 10 different countries
No • 50%
Yes • 50%
Reports from WHO or African health organizations
No • 50%
Yes • 50%
WHO official announcements or press releases
1-5 countries • 25%
More than 15 countries • 25%
11-15 countries • 25%
6-10 countries • 25%
Official health department announcements globally
More than 60% • 25%
Less than 20% • 25%
20-40% • 25%
41-60% • 25%
Market analysis reports from industry analysts or financial reports from Abbott
Africa • 25%
Asia • 25%
Europe • 25%
South America • 25%
Regional health reports or WHO announcements